TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/11/22 07:01 | 10/10/22 | BCDA | Biocardia, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McClung David | CA | O | CFO | P | 4 | 2.07 | 0 | 2 | 3 | 79 | D | ||||||||||||||
11/7/18 16:40 | 11/5/18 | BCDA | Biocardia, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McClung David | CA | O | CFO | P | 4 | 2.56 | 0 | 2 | 35 | 6 | D | ||||||||||||||
10/16/18 16:34 | 10/12/18 | BCDA | Biocardia, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McClung David | CA | O | CFO | P | 1 | 2.64 | 0 | 1 | 12 | 5 | D | ||||||||||||||
9/25/18 20:57 | 9/25/18 | BCDA | Biocardia, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McClung David | CA | O | CFO | P | 7 | 2.45 | 0 | 3 | 228 | 4 | D | ||||||||||||||
3/22/18 21:52 | 3/22/18 | BCDA | Biocardia, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McClung David | CA | DO | CFO | P | 1 | 1.90 | 0 | 1 | 67 | 1 | D | ||||||||||||||
3/22/18 14:25 | 3/21/18 | BCDA | Biocardia, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McClung David | CA | O | CFO | P | 1 | 1.90 | 0 | 1 | New | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |